News

Postmenopausal women on tirzepatide show lower weight loss than those typically seen with the obesity drug, but weight loss ...
In patients with obesity, tirzepatide improved cardiometabolic parameters and risk for cardiovascular disease, but the ...
Tirzepatide reduces breast tumor growth in obese mice while improving metabolic health, offering hope as a dual-action cancer ...
SAN FRANCISCO -- Menopause hormone therapy (MHT) was tied to a weight-loss boost in postmenopausal women taking a weight loss ...
Popular weight loss medications like Ozempic can help reverse low testosterone levels in men with obesity or Type 2 diabetes, ...
Your blood sugar can affect more than your propensity for diabetes. In fact, high blood sugar may be causing you to lose out ...
By Dennis Thompson HealthDay ReporterMONDAY, July 14, 2025 (HealthDay News) — Good news for women of a certain age: Hormone ...
Popular anti-obesity medications continue to be effective for weight loss even when availability and access is interrupted, ...
Explore the growing GLP-1 agonists market, driven by rising diabetes and obesity rates. Discover advancements in therapies like Tirzepatide and GZR18, offering both glycemic control and weight loss ...
WEIGHT loss jabs could boost men’s sex lives, a study suggests. Research found injections like Wegovy and Mounjaro can raise ...
New research finds that men taking a GLP-1 for their obesity or type 2 diabetes often experience a rise in testosterone ...